13. Oct 2026
Description
(AWP Alliance News) - Galderma disclosed new results from an eight-month investigator-initiated clinical trial in menopausal women testing a combined injectable aesthetics protocol for the face and décolletage. The study results were presented in the announcement.
The data showed the paired regimen improved skin hydration and overall skin quality with benefits that held up over time. It also found that starting with Restylane Skinboosters then moving to Sculptra produced faster visible improvement than the reverse sequence.
Reported patient satisfaction was high, with most participants describing natural-looking outcomes and indicating they would recommend the treatment.
https://www.businesswire.com/news/home/20261012641517/en/
Disclaimer: This news brief was created using generative artificial intelligence. Galderma Group AG published the original content used to generate this news brief via Business Wire on October 13, 2026, and is solely responsible for the information contained therein.
